<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "calcitonin inj VIAL">
<dose><value>4 - 8</value>
<value>1</value>
<value>100</value>
<value>50 - 100</value>
</dose>
<route><value>IM</value>
<value>INTRACUTANEOUSLY</value>
<value>SC</value>
</route>
<strength><value>200 unit/mL</value>
</strength>
<frequency><value>Q12H</value>
<value>Q8H</value>
<value>Q6H</value>
<value>ONCE</value>
<value>DAILY</value>
<value>THREE TIMES WEEKLY</value>
</frequency>
<instruction><value>Test Dose: Administer intracutaneously on the flexor surface of the forearm. Observe injection site for 15 minutes for wheal or significant erythema.</value>
</instruction>
<volume><value>2 mL</value>
</volume>
<units><value>unit/kg</value>
<value>unit</value>
</units>
<Population><value>ADULT.</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Hypercalcemia</value>
<value>Hypercalcemia. MAXIMIM dose: 8 unit/kg every 6 hours.</value>
<value>Paget&amp;apos;s Disease. Initial dose.</value>
<value>Paget&amp;apos;s Disease. Maintenance dose.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=2003</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Parathyroid</value>
</AHFSName>
<HighAlert></HighAlert>
</drug>